Sun Ku Lee is a seasoned professional in the pharmaceutical industry, currently serving as the Senior Director of PK/PD/Pharmacometrics at Eli Lilly and Company since April 2025. Prior to this role, Sun Ku Lee was the Executive Director at Morphic Therapeutic from April 2024 to April 2025 and held positions at Ultragenyx Pharmaceutical Inc. as Senior Director and Director from January 2019 to April 2024. Sun Ku Lee's experience includes an Associate Director role at Acerta Pharma and an Associate Director position at Bristol-Myers Squibb over a span of seven years. Earlier career highlights include serving as a Senior Research Investigator at Covance and as a Staff Scientist at Hoffmann-La Roche. Sun Ku Lee earned a Ph.D. in Toxicology from Colorado State University between 1999 and 2004.
This person is not in any teams
This person is not in any offices